Title | Type | SJR | H index | Total Docs. (2013) | Total Docs. (3years) | Total Refs. (2013) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2013) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Recent Patents on Anti-Cancer Drug Discovery | journal | 1.162 Q1 | 52 | 24 | 77 | 3422 | 229 | 71 | 2.84 | 142.58 | |
2 | Current Neuropharmacology | journal | 0.951 Q1 | 103 | 48 | 170 | 6542 | 547 | 161 | 2.60 | 136.29 | |
3 | Current Medicinal Chemistry | journal | 1.373 Q1 | 202 | 359 | 1223 | 41513 | 5433 | 1164 | 4.02 | 115.64 | |
4 | Current Vascular Pharmacology | journal | 0.783 Q2 | 69 | 94 | 268 | 10596 | 775 | 248 | 2.82 | 112.72 | |
5 | Recent Patents on CNS Drug Discovery | journal | 0.940 Q2 | 36 | 18 | 64 | 2003 | 181 | 57 | 2.90 | 111.28 | |
6 | Current Immunology Reviews | journal | 0.351 Q3 | 23 | 27 | 133 | 2980 | 123 | 120 | 0.49 | 110.37 | |
7 | Current Pharmaceutical Design | journal | 1.295 Q1 | 183 | 659 | 1399 | 71581 | 5281 | 1284 | 3.55 | 108.62 | |
8 | Recent Patents on Endocrine, Metabolic and Immune Drug Discovery | journal | 0.424 Q2 | 28 | 23 | 74 | 2456 | 126 | 72 | 2.38 | 106.78 | |
9 | Current Cancer Drug Targets | journal | 1.585 Q1 | 103 | 82 | 269 | 8657 | 1036 | 249 | 3.79 | 105.57 | |
10 | Current Diabetes Reviews | journal | 1.479 Q1 | 68 | 47 | 143 | 4757 | 597 | 141 | 4.23 | 101.21 | |
11 | Current Topics in Medicinal Chemistry | journal | 1.268 Q1 | 133 | 241 | 600 | 23758 | 2286 | 526 | 3.62 | 98.58 | |
12 | Current Protein and Peptide Science | journal | 1.347 Q1 | 96 | 74 | 223 | 7291 | 585 | 194 | 2.30 | 98.53 | |
13 | Recent advances in inflammation & allergy drug discovery | journal | 37 | 23 | 74 | 2232 | 146 | 72 | 2.16 | 97.04 | ||
14 | Current Cancer Therapy Reviews | journal | 0.236 Q3 | 17 | 26 | 101 | 2513 | 49 | 95 | 0.43 | 96.65 | |
15 | Current Molecular Pharmacology | journal | 1.455 Q1 | 49 | 20 | 71 | 1907 | 251 | 65 | 2.88 | 95.35 | |
16 | Recent Patents on Nanotechnology | journal | 0.395 Q2 | 36 | 20 | 61 | 1896 | 106 | 59 | 1.73 | 94.80 | |
17 | Current Nanomedicine | journal | 8 | 6 | 0 | 566 | 0 | 0 | 0.00 | 94.33 | ||
18 | Current Genomics | journal | 1.464 Q2 | 77 | 55 | 190 | 5074 | 732 | 177 | 3.50 | 92.25 | |
19 | Recent Advances in Anti-Infective Drug Discovery | journal | 38 | 24 | 71 | 2171 | 145 | 69 | 2.10 | 90.46 | ||
20 | Recent patents on food, nutrition & agriculture | journal | 0.368 Q2 | 33 | 22 | 69 | 1990 | 97 | 68 | 1.26 | 90.45 | |
21 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.495 Q2 | 45 | 26 | 75 | 2332 | 108 | 69 | 1.10 | 89.69 | |
22 | Mini-Reviews in Medicinal Chemistry | journal | 0.939 Q1 | 107 | 164 | 355 | 14556 | 1230 | 337 | 3.42 | 88.76 | |
23 | Current Gene Therapy | journal | 2.047 Q1 | 80 | 46 | 142 | 4073 | 754 | 126 | 5.45 | 88.54 | |
24 | Current Chemical Biology | journal | 0.325 Q3 | 26 | 26 | 78 | 2291 | 77 | 73 | 0.87 | 88.12 | |
25 | Current Drug Targets | journal | 1.548 Q1 | 119 | 174 | 546 | 14997 | 2193 | 496 | 3.67 | 86.19 | |
26 | Current Proteomics | journal | 0.239 Q4 | 27 | 32 | 88 | 2751 | 55 | 81 | 0.51 | 85.97 | |
27 | Current Organic Synthesis | journal | 0.870 Q2 | 55 | 63 | 141 | 5229 | 316 | 129 | 2.34 | 83.00 | |
28 | Recent Advances in Drug Delivery and Formulation | journal | 41 | 22 | 58 | 1821 | 109 | 55 | 1.90 | 82.77 | ||
29 | Mini-Reviews in Organic Chemistry | journal | 0.368 Q3 | 43 | 37 | 126 | 2927 | 132 | 115 | 0.90 | 79.11 | |
30 | Current Enzyme Inhibition | journal | 0.231 Q3 | 19 | 18 | 60 | 1416 | 41 | 55 | 0.51 | 78.67 | |
31 | Current Angiogenesis | journal | 0.148 Q4 | 6 | 20 | 25 | 1549 | 16 | 24 | 0.64 | 77.45 | |
32 | Current Organic Chemistry | journal | 1.002 Q2 | 112 | 268 | 582 | 20635 | 1573 | 535 | 2.44 | 77.00 | |
33 | Infectious Disorders - Drug Targets | journal | 0.707 Q2 | 61 | 38 | 139 | 2911 | 264 | 125 | 1.68 | 76.61 | |
34 | Anti-Cancer Agents in Medicinal Chemistry | journal | 1.122 Q1 | 108 | 174 | 321 | 13259 | 994 | 287 | 2.85 | 76.20 | |
35 | Current Signal Transduction Therapy | journal | 0.242 Q3 | 22 | 33 | 107 | 2500 | 66 | 96 | 0.61 | 75.76 | |
36 | Current Stem Cell Research and Therapy | journal | 0.906 Q1 | 63 | 58 | 136 | 4350 | 495 | 128 | 3.30 | 75.00 | |
37 | GeoArabia | journal | 0.335 Q3 | 63 | 19 | 106 | 1422 | 91 | 92 | 0.73 | 74.84 | |
38 | CNS and Neurological Disorders - Drug Targets | journal | 1.287 Q1 | 96 | 140 | 308 | 10449 | 972 | 269 | 2.61 | 74.64 | |
39 | Recent Patents on Biotechnology | journal | 0.469 Q2 | 42 | 22 | 61 | 1614 | 104 | 58 | 1.55 | 73.36 | |
40 | Current Cardiology Reviews | journal | 0.699 Q2 | 58 | 41 | 123 | 2899 | 298 | 113 | 1.29 | 70.71 | |
41 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | journal | 0.160 Q3 | 27 | 29 | 108 | 2027 | 52 | 97 | 0.51 | 69.90 | |
42 | Current Hypertension Reviews | journal | 0.193 Q3 | 27 | 40 | 111 | 2749 | 55 | 103 | 0.39 | 68.73 | |
43 | Current Drug Discovery Technologies | journal | 0.714 Q2 | 49 | 33 | 101 | 2258 | 273 | 91 | 2.40 | 68.42 | |
44 | Endocrine, Metabolic and Immune Disorders - Drug Targets | journal | 0.836 Q2 | 63 | 43 | 110 | 2930 | 256 | 102 | 2.51 | 68.14 | |
45 | Central Nervous System Agents in Medicinal Chemistry | journal | 0.811 Q2 | 39 | 23 | 97 | 1530 | 226 | 87 | 1.82 | 66.52 | |
46 | Current Bioactive Compounds | journal | 0.288 Q2 | 31 | 27 | 98 | 1793 | 72 | 86 | 0.64 | 66.41 | |
47 | Current Drug Therapy | journal | 0.126 Q4 | 20 | 21 | 106 | 1374 | 30 | 99 | 0.33 | 65.43 | |
48 | Current Computer-Aided Drug Design | journal | 0.511 Q2 | 32 | 52 | 84 | 3394 | 162 | 76 | 1.77 | 65.27 | |
49 | Rehabilitation Research and Practice | journal | 13 | 1 | 0 | 64 | 0 | 0 | 0.00 | 64.00 | ||
50 | Journal of Immunology Research | journal | 1.258 Q1 | 113 | 303 | 498 | 18927 | 1755 | 478 | 3.45 | 62.47 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®